Cite
APA Citation
Deodhar, A., Baraliakos, X., Marzo-Ortega, H., Sieper, J., Andersson, M., Porter, B., & Fox, T. (n.d.). tHU0359 Secukinumab demonstrates consistent safety over long-term exposure (up to 3 years) in patients with active ankylosing spondylitis: pooled analysis of three phase 3 trials. Annals of the rheumatic diseases, 76, 340–341. http://access.bl.uk/ark:/81055/vdc_100135163390.0x000062